Pig Kidney Functions in Man for Record 271 Days

A man has successfully lived for a record 271 days with a transplanted pig kidney, marking a significant milestone in xenotransplantation research. This achievement, reported by Massachusetts General Hospital (MGH) and Harvard Medical School, surpasses previous records for pig kidney transplants in human recipients. The recipient, who wishes to remain anonymous, received the genetically modified pig kidney on March 16, 2024, as part of an experimental procedure. The kidney was provided by eGenesis, a biotech firm specializing in xenotransplantation. This procedure involved a kidney from a pig that had undergone 69 gene edits to make it more compatible with the human body and reduce the risk of rejection. Specifically, eGenesis removed genes that could cause harmful immune responses and added human genes to enhance compatibility. The pig also lacked three genes that could lead to hyperacute rejection, a rapid and severe immune response. The transplanted kidney has been functioning well, producing urine and clearing waste products from the man's blood, thereby eliminating the need for dialysis. This success follows earlier experimental transplants, including a pig kidney transplanted into another man in July 2023, which functioned for 32 days, and a pig heart transplanted into a man in January 2022, which functioned for two months. The extended functionality of the pig kidney in this latest case suggests a growing understanding of how to overcome the immunological barriers inherent in xenotransplantation. Researchers at MGH have been at the forefront of this field, aiming to address the critical shortage of human organs available for transplantation. The World Health Organization estimates that the demand for organs far outstrips supply globally, leading to long waiting lists and preventable deaths. Xenotransplantation, the transplantation of organs or tissues from one species to another, offers a potential solution to this organ deficit. The use of genetically modified pigs is favored due to their physiological similarities to humans and their rapid reproductive rates, making them a viable source for organ production. The long-term success of this procedure will continue to be monitored closely, with further research focused on refining gene-editing techniques and immunosuppressive regimens to ensure sustained graft survival and patient well-being. The implications of this breakthrough extend beyond kidney transplantation, potentially paving the way for the transplantation of other vital organs, such as hearts and livers, from pigs to humans in the future. This development represents a critical step forward in the quest to provide life-saving organ transplants to a greater number of patients.